サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：潜在性結核感染症（LTBI）検出の世界市場規模調査・予測：検査タイプ別、エンドユーザー別、地域別分析、2022-2029年
市場調査レポート
商品コード
1215393

潜在性結核感染症（LTBI）検出の世界市場規模調査・予測：検査タイプ別、エンドユーザー別、地域別分析、2022-2029年

Global Latent Tuberculosis Infection Detection Market Size study & Forecast, by Test Type, by End-User and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.94円
潜在性結核感染症（LTBI）検出の世界市場規模調査・予測：検査タイプ別、エンドユーザー別、地域別分析、2022-2029年
出版日: 2023年02月08日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

潜伏性結核感染症は、結核菌が体内で眠った状態で活動しない結核感染症の一種です。

ツベルクリン反応検査（TST）により発見されます。薬物乱用、HIV、免疫力を低下させる薬物など、他の病気によってリスクが高まります。結核検査に対する需要の急増、疾病治療を管理するための資金調達の増加、老年人口の増加などの要因が、世界の市場成長の原動力となっています。

潜在性結核感染症（LTBI）から活動性結核を発症するリスクの高まりは、全世界の市場需要を促進しています。TBFacts.orgによると、2021年にはインド人の約40％が結核菌に感染していると推定され、その大多数は活動性結核疾患の代わりに潜在性結核を患っているとされています。同様に、米国疾病管理予防センターの報告書2021年によると、米国では最大で1300万人が潜在性結核感染症に苦しんでいると推定されています。したがって、人口の潜在的な結核感染の高い有病率は、市場の成長を増強しています。さらに、非政府組織や市場関係者が実施する啓発キャンペーンの増加や、潜在性結核を治療するための政府の取り組みが増加していることが、今後数年間で複数の機会を生んでいます。しかし、結核のスクリーニングに対する体系的なアプローチの欠如、適切な勧告や償還政策の不在が、2022-2029年の予測期間を通じて市場の成長を妨げています。

世界の潜在性結核感染症検出市場の調査において考慮された主要地域は、アジア太平洋、北米、欧州、中南米、世界のその他の地域です。北米は、感染の早期診断に関する意識の高まり、結核管理のための高い資金調達、医療施設の改善などにより、収益面で市場を独占しています。一方、アジア太平洋地域は、予測期間中に最も高いCAGRで成長すると予想されています。新興国における高い感染率、人口の増加、政府による有利な取り組みなどの要因が、予測期間中の市場成長を急拡大させています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むことを目的としています。

また、市場の将来的な成長を定義する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・セグメンテーション市場の推定・予測、2019年～2029年
    • 潜在性結核感染症検出市場：地域別、2019年～2029年
    • 潜在性結核感染症検出市場：検査タイプ別、2019年～2029年
    • 潜在性結核感染症検出市場：エンドユーザー別、2019年～2029年
  • 主な動向
  • 調査手法
  • 調査前提条件

第2章 潜伏性結核感染症検出の世界市場定義とスコープ

  • 調査の目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 調査対象年
  • 通貨換算レート

第3章 世界の潜伏性結核感染症検出市場力学

  • 潜伏性結核感染症検出市場のインパクト分析（2019-2029年）
    • 市場促進要因
      • 潜在性結核感染症（LTBI）から活動性結核を発症するリスクの上昇
      • 結核検査に対する需要の急増
    • 市場の課題
      • 結核のスクリーニングに対する体系的なアプローチの欠如
      • 適切な推奨事項や償還政策の欠如
    • 市場機会
      • 非政府組織や市場関係者別啓発キャンペーンの増加
      • 潜在性結核の治療に対する政府のイニシアチブの増加

第4章 世界の潜伏性結核感染症検出市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • トップ投資機会
  • 主要成功戦略
  • 業界専門家別展望
  • アナリストの結論・提言

第5章 リスク評価：COVID-19のインパクト

  • COVID-19が業界に与える全体的な影響の評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 潜伏性結核感染症検出の世界市場：検査タイプ別

  • 市場スナップショット
  • 検査タイプ別潜伏性結核感染症検出の世界市場、性能-ポテンシャル分析
  • 世界の潜在性結核感染症検出市場の検査タイプ別推定・予測2019～2029年
  • 潜在性結核感染症検出市場、サブセグメント分析
    • ツベルクリン皮膚反応検査
    • インターフェロンガンマ放出アッセイ

第7章：潜伏性結核感染症検出の世界市場：エンドユーザー別

  • 市場スナップショット
  • 潜在性結核感染症検出の世界市場：エンドユーザー別、性能-ポテンシャル分析
  • エンドユーザー別潜伏性結核感染検出の世界市場推定・予測：2019-2029年
  • 潜伏性結核感染症検出市場、サブセグメント分析
    • 診断ラボラトリー
    • 病院/クリニック
    • 学術・研究機関

第8章 潜伏性結核感染症検出の世界市場：地域別分析

  • 潜伏性結核菌感染症検出市場の地域別市場スナップショット
  • 北米
    • 米国
      • 検査タイプ別の推定・予測、2019年～2029年
      • エンドユーザー別の推定・予測、2019年～2029年
    • カナダ
  • 欧州潜伏結核感染症検出市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州地域
  • アジア太平洋地域の潜伏性結核感染症検出市場のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの潜在性結核感染症検出市場のスナップショット
    • ブラジル
    • メキシコ
    • その他のラテンアメリカ地域
  • 世界のその他の地域

第9章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • QIAGEN N.V.
      • 主要情報
      • 概要
      • 財務情報（データの入手状況により異なります）
      • 製品概要
      • 最近の動向
    • Oxford Immunotec Inc.
    • F. Hoffmann-La Roche Ltd.
    • Sanofi S.A.
    • Abbott Laboratories
    • bioMerieux SA
    • Becton, Dickinson, and Company
    • Endo International plc
    • PerkinElmer, Inc.
    • Bruker Corporation

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査属性
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Latent Tuberculosis Infection Detection Market, report scope
  • TABLE 2. Global Latent Tuberculosis Infection Detection Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Latent Tuberculosis Infection Detection Market estimates & forecasts by Test Type 2019-2029 (USD Billion)
  • TABLE 4. Global Latent Tuberculosis Infection Detection Market estimates & forecasts by End-User 2019-2029 (USD Billion)
  • TABLE 5. Global Latent Tuberculosis Infection Detection Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Latent Tuberculosis Infection Detection Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Latent Tuberculosis Infection Detection Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Latent Tuberculosis Infection Detection Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Latent Tuberculosis Infection Detection Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Latent Tuberculosis Infection Detection Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Latent Tuberculosis Infection Detection Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Latent Tuberculosis Infection Detection Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Latent Tuberculosis Infection Detection Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Latent Tuberculosis Infection Detection Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Latent Tuberculosis Infection Detection Market
  • TABLE 70. List of primary sources, used in the study of global Latent Tuberculosis Infection Detection Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Latent Tuberculosis Infection Detection Market, research methodology
  • FIG 2. Global Latent Tuberculosis Infection Detection Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Latent Tuberculosis Infection Detection Market, key trends 2021
  • FIG 5. Global Latent Tuberculosis Infection Detection Market, growth prospects 2022-2029
  • FIG 6. Global Latent Tuberculosis Infection Detection Market, porters 5 force model
  • FIG 7. Global Latent Tuberculosis Infection Detection Market, pest analysis
  • FIG 8. Global Latent Tuberculosis Infection Detection Market, value chain analysis
  • FIG 9. Global Latent Tuberculosis Infection Detection Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Latent Tuberculosis Infection Detection Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Latent Tuberculosis Infection Detection Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Latent Tuberculosis Infection Detection Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Latent Tuberculosis Infection Detection Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Latent Tuberculosis Infection Detection Market, regional snapshot 2019 & 2029
  • FIG 15. North America Latent Tuberculosis Infection Detection Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Latent Tuberculosis Infection Detection Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia Pacific Latent Tuberculosis Infection Detection Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Latent Tuberculosis Infection Detection Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Latent Tuberculosis Infection Detection Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Latent Tuberculosis Infection Detection Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Latent Tuberculosis Infection (LTBI) is a variety of TB infection in which bacteria remains inactive specifically bacteria that exists in the sleeping state inside the individual's body. The detection of this infection is identified by the tuberculin skin test (TST). The risk is increased by other diseases including drug abuse, HIV, or medications that weakens the immune system. Factors such as surging demand for tuberculosis testing, growing funding to manage disease treatment, and increasing geriatric population are driving the market growth globally.

The rising risk of developing active TB from latent tuberculosis infection (LTBI) is propelling the demand for market across the globe. According to TBFacts.org, in 2021, about 40% of Indians are estimated to be infected with the TB bacteria, with the great majority having latent TB instead of active TB disease. Likewise, according to the Centers for Disease Control and Prevention report 2021, it was estimated that up to 13 million people in the United States suffered from latent TB infection. Therefore, the high prevalence rate of latent tuberculosis infection among the population is augmenting the market growth. Furthermore, growing awareness campaigns conducted by non-government bodies and market players, as well as a rising number of government initiatives to treat LTBI are leveraging multiple opportunities in the foreseen years. However, the lack of a systematic approach to screening tuberculosis and the unavailability of proper recommendations and reimbursement policies are hindering market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Latent Tuberculosis Infection Detection Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the growing awareness about early diagnosis of infection, high funding for tuberculosis management, and improvement of healthcare facilities. Whereas, Asia Pacific is expected to grow at the highest CAGR during the forecast period. Factors such as high infection rates in developing countries, increasing population, as well as government favorable initiatives are burgeoning the market growth in the forecasting years.

Major market players included in this report are:

QIAGEN N.V.

Oxford Immunotec Inc.

F. Hoffmann-La Roche Ltd.

Sanofi S.A.

Abbott Laboratories

bioMerieux SA

Becton, Dickinson, and Company

Endo International plc

PerkinElmer, Inc.

Bruker Corporation

Recent Developments in the Market:

  • In February 2022, QIAGEN N.V. announced that the company received approval for its QuantiFERON tuberculosis testing solution in China. With this strategic initiative company aims to boost its market share across the region.

Global Latent Tuberculosis Infection Detection Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Test Type, End-User, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Test Type:

Tuberculin Skin Test

Interferon Gamma Release Assays

By End User:

Diagnostic Laboratories

Hospitals/Clinics

Academic & Research Institutions

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

ROLA

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Latent Tuberculosis Infection Detection Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Latent Tuberculosis Infection Detection Market, by Test Type, 2019-2029 (USD Billion)
    • 1.2.3. Latent Tuberculosis Infection Detection Market, by End-User, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Latent Tuberculosis Infection Detection Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Latent Tuberculosis Infection Detection Market Dynamics

  • 3.1. Latent Tuberculosis Infection Detection Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising risk of developing active TB from latent tuberculosis infection (LTBI)
      • 3.1.1.2. Surging demand for tuberculosis testing
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack of a systematic approach to screening tuberculosis
      • 3.1.2.2. Unavailability of proper recommendations and reimbursement policies
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing awareness campaigns conducted by non-government bodies and market players
      • 3.1.3.2. Rising number of government initiatives to treat LTBI

Chapter 4. Global Latent Tuberculosis Infection Detection Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Latent Tuberculosis Infection Detection Market, by Test Type

  • 6.1. Market Snapshot
  • 6.2. Global Latent Tuberculosis Infection Detection Market by Test Type, Performance - Potential Analysis
  • 6.3. Global Latent Tuberculosis Infection Detection Market Estimates & Forecasts by Test Type 2019-2029 (USD Billion)
  • 6.4. Latent Tuberculosis Infection Detection Market, Sub Segment Analysis
    • 6.4.1. Tuberculin Skin Test
    • 6.4.2. Interferon Gamma Release Assays

Chapter 7. Global Latent Tuberculosis Infection Detection Market, by End-User

  • 7.1. Market Snapshot
  • 7.2. Global Latent Tuberculosis Infection Detection Market by End-User, Performance - Potential Analysis
  • 7.3. Global Latent Tuberculosis Infection Detection Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
  • 7.4. Latent Tuberculosis Infection Detection Market, Sub Segment Analysis
    • 7.4.1. Diagnostic Laboratories
    • 7.4.2. Hospitals/Clinics
    • 7.4.3. Academic & Research Institutions

Chapter 8. Global Latent Tuberculosis Infection Detection Market, Regional Analysis

  • 8.1. Latent Tuberculosis Infection Detection Market, Regional Market Snapshot
  • 8.2. North America Latent Tuberculosis Infection Detection Market
    • 8.2.1. U.S. Latent Tuberculosis Infection Detection Market
      • 8.2.1.1. Test Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. End-User breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Latent Tuberculosis Infection Detection Market
  • 8.3. Europe Latent Tuberculosis Infection Detection Market Snapshot
    • 8.3.1. U.K. Latent Tuberculosis Infection Detection Market
    • 8.3.2. Germany Latent Tuberculosis Infection Detection Market
    • 8.3.3. France Latent Tuberculosis Infection Detection Market
    • 8.3.4. Spain Latent Tuberculosis Infection Detection Market
    • 8.3.5. Italy Latent Tuberculosis Infection Detection Market
    • 8.3.6. Rest of Europe Latent Tuberculosis Infection Detection Market
  • 8.4. Asia-Pacific Latent Tuberculosis Infection Detection Market Snapshot
    • 8.4.1. China Latent Tuberculosis Infection Detection Market
    • 8.4.2. India Latent Tuberculosis Infection Detection Market
    • 8.4.3. Japan Latent Tuberculosis Infection Detection Market
    • 8.4.4. Australia Latent Tuberculosis Infection Detection Market
    • 8.4.5. South Korea Latent Tuberculosis Infection Detection Market
    • 8.4.6. Rest of Asia Pacific Latent Tuberculosis Infection Detection Market
  • 8.5. Latin America Latent Tuberculosis Infection Detection Market Snapshot
    • 8.5.1. Brazil Latent Tuberculosis Infection Detection Market
    • 8.5.2. Mexico Latent Tuberculosis Infection Detection Market
    • 8.5.3. Rest of Latin America Latent Tuberculosis Infection Detection Market
  • 8.6. Rest of The World Latent Tuberculosis Infection Detection Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. QIAGEN N.V.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Oxford Immunotec Inc.
    • 9.2.3. F. Hoffmann-La Roche Ltd.
    • 9.2.4. Sanofi S.A.
    • 9.2.5. Abbott Laboratories
    • 9.2.6. bioMerieux SA
    • 9.2.7. Becton, Dickinson, and Company
    • 9.2.8. Endo International plc
    • 9.2.9. PerkinElmer, Inc.
    • 9.2.10. Bruker Corporation

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption